Imricor Medical Systems has raised $1.5 million in a new round of debt and securities financing, according to an SEC filing posted this week. Money in the funding round came from 19 unnamed investors, with the date of the first sale reported on April 4, 2018. The company is not looking to raise any more money […]
Data from a study of device-related blood clots and the Watchman cardiac implant made by Boston Scientific (NYSE:BSX), presented today at the annual meeting of the Heart Rhythm Society in Boston, indicate the need for aggressive management of patients at risk for device-related thrombosis. There were 74 incidences of DRT in 65 of the 1,739 Watchman […]
Imricor Medical Systems said today it won CE Mark approval in the European Union for its Advantage-MR EP recorder/stimulator system, designed to allow for MRI-guided electrophysiology procedures. The system, along with MR-compatible ablation catheters, will allow operating physicians to perform cardiac ablations using real-time MRI guidance, which the Minneapolis, Minn.-based company said could improve safety […]
By Thomas Lee
BURNSVILLE, Minnesota– Imricor Medical Systems Inc. raised $3.1 million, according to a filing with the federal Securities and Exchange Commission.
Working with General Electric (NYSE:GE), a major maker of MRI machines, Imricor is developing an MRI-guided catheter system to treat cardiac arrhythmias like atrial fibrillation.